戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 mp CABG (with or without valve surgery) with blood cardioplegia.
2 anced in the coronary microcirculation after blood cardioplegia.
3 ulmonary bypass and randomized to either all-blood cardioplegia (AB group) or dilute blood cardiopleg
4 nutes of 10 degrees C antegrade intermittent blood cardioplegia and 30 minutes of reperfusion.
5                In this study, the effects of blood cardioplegia and brief reperfusion on vascular rea
6                                              Blood cardioplegia and combined antegrade and retrograde
7                                     Both all-blood cardioplegia and dilute cardioplegia have disadvan
8 s C) antegrade potassium all-blood or dilute blood cardioplegia and maintained with tepid retrograde
9 vested from patients (n=15) before and after blood cardioplegia and short-term reperfusion under cond
10  this, early death (6% crystalloid versus 4% blood cardioplegia) and late death (24% crystalloid vers
11 L)-supplemented blood (RSR13-BC) to standard blood cardioplegia (BC).
12 of ONOO(-) may exist between crystalloid and blood cardioplegia (BCP) environments.
13  tested the hypothesis that ADO-supplemented blood cardioplegia (BCP) or ADO administered during repe
14 of the intraoperative administration of cold blood cardioplegia, blood cardioplegia containing 500 mi
15          Cardioplegic arrest (CA) using cold blood cardioplegia (CBC) has been reported to reduce isc
16 oplegia containing 500 microM adenosine, and blood cardioplegia containing 2 mM adenosine.
17 e administration of cold blood cardioplegia, blood cardioplegia containing 500 microM adenosine, and
18  all-blood cardioplegia (AB group) or dilute blood cardioplegia (Dil group).
19 ditioning activation adjuvant to hypothermic blood cardioplegia enhances postischemic contractile rec
20 loid cardioplegia (iC-CCP; n=8) or with cold blood cardioplegia (iC-BCP; n=6) administered intermitte
21 ety and tolerance of adenosine when added to blood cardioplegia in increasing doses to enhance myocar
22                            The advantages of blood cardioplegia include the oxygen-carrying capacity,
23 oid cardioplegia (iW-CCP) (n=8) or with warm blood cardioplegia (iW-BCP) (n=8) administered intermitt
24 atrial segment exposed to cold, hyperkalemic blood cardioplegia (mean, 60 minutes) and a brief period
25 o determine the effect, if any, of adenosine blood cardioplegia on blood component usage after heart
26                           During hypothermic blood cardioplegia, oxygen delivery to myocytes is minim
27 ) and late death (24% crystalloid versus 21% blood cardioplegia) statistics were not significantly di
28 stalloid cardioplegia versus those receiving blood cardioplegia were found to have significantly more

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。